Communication
Organic & Biomolecular Chemistry
Angew. Chem., Int. Ed., 2001, 40, 2251; (g) A. de Meijere,
Top. Curr. Chem., 2000, 207, 1.
2 (a) R. Ballini, A. Palmieri and D. Fiorini, ARKIVOC, 2007, 7,
172; (b) B. D. Zlatopolskiy, K. Loscha, P. Alvermann,
S. I. Kozhushkov, S. V. Nikolaev, A. Zeeck and A. de
Meijere, Chem.–Eur. J., 2004, 10, 4708; (c) J. Zindel and
A. de Meijere, J. Org. Chem., 1995, 60, 2968.
Scheme 1 Synthesis of ent-3g starting from 4 and 5.
3 For reviews on nitrocyclopropanes, see: (a) B. Moreau,
D. Alberico, V. N. G. Lindsay and A. B. Charette, Tetra-
hedron, 2012, 68, 3487; (b) E. B. Averina, N. V. Yashin,
T. S. Kuznetsova and N. S. Zefirov, Russ. Chem. Rev., 2009,
78, 887; for selected examples, see: (c) S. S. So, T. J. Auvil,
V. J. Garza and A. E. Mattson, Org. Lett., 2012, 14, 444;
(d) V. N. G. Lindsay, C. Nicolas and A. B. Charette, J. Am.
Chem. Soc., 2011, 133, 8972; (e) O. Lifchits, D. Alberico,
I. Zakharian and A. B. Charette, J. Org. Chem., 2008, 73,
6838; (f) E. M. Budynina, O. A. Ivanova, E. B. Averina,
T. S. Kuznetsova and N. S. Zefirov, Tetrahedron Lett., 2006,
47, 647; (g) R. P. Wurz and A. B. Charette, J. Org. Chem.,
2004, 69, 1262.
4 For reviews, see: (a) H. Pellissier, Tetrahedron, 2008, 64,
7041; (b) H. Lebel, J. F. Marcoux, C. Molinaro and
A. B. Charette, Chem. Rev., 2003, 103, 977; for recent
examples, see: (c) S. R. Goudreau and A. B. Charette, J. Am.
Chem. Soc., 2009, 131, 15633; (d) L. E. Zimmer and
A. B. Charette, J. Am. Chem. Soc., 2009, 131, 15624.
(entry 16).18 The absolute configuration of 3a and 3k were
determined by single crystal X-ray data analyses and those of
the others were assigned by analogy.19
We believe that the reaction proceeds through simultaneous
activation of the pronucleophile (bromonitroalkane) and
electrophilic 2-arylidene-1,3-indandiones via water assisted
H-bonding interaction by the bifunctional catalyst. Nucleo-
philic addition of bromonitroalkane and subsequent intra-
molecular cyclisation furnished the desired spirocyclopropane
products (see ref. 10d).
Furthermore, we envisioned that spirocyclopropane product
(3g) can also be accessed by employing bromonitrostyrene,
such as 4, as a dielectrophilic component10a,20 and 1,3-indan-
dione (5) as a dinucleophile in presence of appropriate cata-
lyst. However, our initial attempt to use the present optimized
reaction conditions was not very successful and the adduct
ent-3g was obtained with only 35% ee and moderate yield
(57%) (Scheme 1).
In summary, we have developed an efficient asymmetric
pathway for the preparation of spironitrocyclopropanes cata-
lyzed by cinchona-derived bifunctional organocatalysts. To the
best of our knowledge, this is the first asymmetric route to
prepare spironitrocyclopropanes starting from 2-arylidene-1,3-
indandiones and bromonitroalkanes. The products were
obtained in good yields (up to 88%), excellent enantioselec-
tivities (up to 98%) and diastereoselectivities (up to 19 : 1).
Further investigation of the synthetic route described in
Scheme 1, biological evaluation of spironitrocyclopropanes
and investigation of the reaction mechanism are currently
underway in our laboratory.
5 For selected recent examples see: (a) X. Xu, H. Lu,
J. V. Ruppel, X. Cui, S. L. de Mesa, L. Wojtas and
X. P. Zhang, J. Am. Chem. Soc., 2011, 133, 15292; (b) J.-i. Ito,
S. Ujiie and H. Nishiyama, Chem.–Eur. J., 2010, 16, 4986;
(c) S. Zhu, X. Xu, J. A. Perman and X. P. Zhang, J. Am. Chem.
Soc., 2010, 132, 12796; (d) S. Chuprakov, S. W. Kwok,
L. Zhang, L. Lercher and V. V. Fokin, J. Am. Chem. Soc.,
2009, 131, 18034; (e) M. Ichinose, H. Suematsu and
T. Katsuki, Angew. Chem., Int. Ed., 2009, 48, 3121.
6 (a) S. L. Riches, C. Saha, N. F. Filgueira, E. Grange,
E. M. McGarrigle and V. K. Aggarwal, J. Am. Chem. Soc.,
2010, 132, 7626; (b) V. K. Aggarwal, E. Alonso, G. Fang,
M. Ferrara, G. Hynd and M. Porcelloni, Angew. Chem., Int.
Ed., 2001, 40, 1433.
7 (a) C. C. C. Johansson, N. Bremeyer, S. V. Ley, D. R. Owen,
S. C. Smith and M. J. Gaunt, Angew. Chem., Int. Ed., 2006,
45, 6024; (b) N. Bremeyer, S. C. Smith, S. V. Ley and
M. J. Gaunt, Angew. Chem., Int. Ed., 2004, 43, 2681.
8 (a) R. K. Kunz and D. W. C. MacMillan, J. Am. Chem. Soc.,
2005, 127, 3240; (b) for a related example, see: A. Hartikka
and P. I. Arvidsson, J. Org. Chem., 2007, 72, 5874.
Acknowledgements
The authors thank the National Science Council of the Repub-
lic of China (NSC 99-2119-M-003-004-MY2) and National
Taiwan Normal University (NTNU100-D-06) for financial
support.
9 For recent selected examples in asymmetric cyclopropana-
tions, see: (a) A. Biswas, S. De Sarkar, L. Tebben and
A. Studer, Chem. Commun., 2012, 48, 5190; (b) L. Gao,
G.-S. Hwang and D. H. Ryu, J. Am. Chem. Soc., 2011, 133,
20708; (c) B.-H. Zhu, R. Zhou, J.-C. Zheng, X.-M. Deng,
X.-L. Sun, Q. Shen and Y. Tang, J. Org. Chem., 2010, 75,
3454.
Notes and references
1 (a) D. Y.-K. Chen, R. H. Pouwer and J.-A. Richard, Chem.
Soc. Rev., 2012, 41, 4631; (b) F. Brackmann and A. de
Meijere, Chem. Rev., 2007, 107, 4493; (c) J. A. Thomson and
R. B. Perni, Curr. Opin. Drug Discovery Dev., 2006, 9, 606;
(d) W. A. Donaldson, Tetrahedron, 2001, 57, 8589; 10 (a) X. Dou and Y. Lu, Chem.–Eur. J., 2012, 18, 8315;
(e) J. Pietruszka, Chem. Rev., 2003, 103, 1051; (f) R. Faust,
(b) C. D. Fiandra, L. Piras, F. Fini, P. Disetti, M. Moccia and
46 | Org. Biomol. Chem., 2013, 11, 44–47
This journal is © The Royal Society of Chemistry 2013